Gland Pharma Ltd. Fundamental & Technical Research, Share Price Today

NSE : GLAND
NIFTY : Nifty 500
NIFTY SECTOR : Nifty Pharma

About Company

Gland Pharma Limited is focused on meeting diverse injectables needs with a stable supply of affordable and high quality products. It has established a portfolio of injectable products across various therapeutic areas and delivery systems. It is present in sterile injectables, oncology and ophthalmics, and focus on complex injectables, NCE-1s, First-to-File products and 505(b)(2) filings. Its delivery systems include liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops. It is expanding its development and manufacturing capabilities in complex injectables such as peptides, long-acting injectables, suspensions and hormonal products as well as new delivery systems such as pens and cartridges.

Market Cap. ₹ 32,648 Cr.

52 Week - High/Low ₹ 2,131/1,278

P/E Ratio 28.74

P/B Ratio 3.35

Enterprise Value ₹ 30,358 Cr.

ROE % 11.62

RSI Value 52.32

EMA 50 1936.46

EMA 200 1786.32

Market Cap. ₹ 32,648 Cr.

52 Week - High/Low ₹ 2,131/1,278

P/E Ratio 42.39

P/B Ratio 3.57

Enterprise Value ₹ 30,549 Cr.

ROE % 7.82

RSI Value 52.32

EMA 50 1936.46

EMA 200 1786.32

Add Parameters

Growth

View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Terms | Privacy | Contact Us

Gland Pharma Ltd.

₹1981.6